http://www.kalvista.com
KalVista Pharmaceuticals, Inc. Company Intro
Copyright © 2020 | All rights reserved.
Industry
Healthcare
KalVista Pharmaceuticals, Inc. Headquaters
55 Cambridge Parkway
Cambridge,02142
United States
KalVista Pharmaceuticals, Inc. Share price
25 Jan 2021 01:58 GMT
$15.69
-0.24 (-1.51 %)
KalVista Pharmaceuticals, Inc. Market cap
$289.408 M
WMC RANKING
2021
KalVista Pharmaceuticals, Inc. # 157
BiotechnologyLatest KalVista Pharmaceuticals, Inc. News
12 Jan 2021
GM1 Gangliosidosis Treatment Market Growth Analysis, Margin, Players Analysis, SWOT, Supply Chain Analysis and Key Players – Centogene AG , BioCryst Pharmaceuticals
Takeda Pharmaceutical Company Limited Ionis Pharmaceuticals, Inc. ... BioCryst Pharmaceuticals KalVista Pharmaceuticals, Inc. Key Highlights of the Plasma ...
12 Jan 2021
GM1 Gangliosidosis Treatment Market Growth Analysis, Margin, Players Analysis, SWOT, Supply Chain Analysis and Key Players – Centogene AG , BioCryst Pharmaceuticals
Takeda Pharmaceutical Company Limited Ionis Pharmaceuticals, Inc. ... BioCryst Pharmaceuticals KalVista Pharmaceuticals, Inc. Key Highlights of the Plasma ...
12 Jan 2021
GM1 Gangliosidosis Treatment Market Growth Analysis, Margin, Players Analysis, SWOT, Supply Chain Analysis and Key Players – Centogene AG , BioCryst Pharmaceuticals
Takeda Pharmaceutical Company Limited Ionis Pharmaceuticals, Inc. ... BioCryst Pharmaceuticals KalVista Pharmaceuticals, Inc. Key Highlights of the Plasma ...
WMC Market Score
WMC Market to Revenue Score
KalVista Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| KalVista Pharmaceuticals, Inc. | USD | $14,105 | $50,877 | $-25,723 | $2,858M | 157 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total KalVista Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
KalVista Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
KalVista Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
KalVista Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
KalVista Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| KalVista Pharmaceuticals, Inc. | 0.15 | 0.29 | 1.04 | 0 | 0 | 0 | 0.68 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
